CODEN: MSPAFY
ISSN: 2521-0815 (Print)
ISSN: 2521-0432 (Online)
Creative Commons Attribution CC BY
Matrix Science Pharma (MSP)
Published and Hosted by Wolters Kluwer , Medknow from 2019.
Matrix Science Pharma (MSP) is the journal for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues. We are cordially inviting you to contribute an article to Matrix Science Pharma (MSP). In this journal, we focus on research in key areas of opportunity and challenge in pharmaceutical sciences. Our aim is to publish updated reviews as well as research articles with comprehensive theoretical and experimental details.
INDEXED BY :
Introduction
Matrix Science Pharma (MSP) is the journal for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues..
Aims & Scope
We are cordially inviting you to contribute an article to Matrix Science Pharma (MSP). In this journal, we focus on research in key areas of opportunity and challenge in pharmaceutical sciences. Our aim is to publish updated reviews as well as research articles with comprehensive theoretical and experimental details. Short communications are also accepted; therefore, there is no restriction on the length of a paper. The issue welcomes manuscripts covering a wide range of aspects involved in drug discovery and development. A non exhaustive list of topics that will be considered comprises:
- ADMET
- Animal experimentation
- Assay development
- Biomarkers
- Biomolecules
- Biosensors
- Biotechnology
- Chemical synthesis
- Chemoinformatics
- Cell Biology
- Clinical and Hospital Pharmacy
- Combinatorial chemistry
- Drug delivery (including bioconjuguates and prodrugs)
- Genomics and Proteomics
- High throughput screening
- Hit identification
- Imaging techniques
- In silico experiments
- In vitro studies
- Lead optimization
- Omics
- Pharmaceutical analysis
- Pharmaceutics
- Pharmacogenomics
- Pharmacokinetics
- Pharmaceutical/Medicinal Chemistry
- Pharmacognosy
- Phytochemistry,
- Pharmacology,
- Scale-up
- Structure-activity relationships
- Target selection
Manuscripts submitted to MSP are only accepted on the understanding that (a) they are subject to editorial review (generally by two independent reviewers); (b) they have not been, and will not be, published in whole or in part in any other journal; (c) the recommendations to the most recent version of the declaration statement for the use of experimental animals have been adhered to.
Peer Review Policy
All peer review is single blind and submission is online via Editorial Manager.
Article publishing charge
There is no APC from 2017 to 2020. Authors will pay $300 only from 2021 onwards.
Submission charges
There are no submission charges for this journal.
Acceptance
Final Decision
Publication
APC